WINNER: Skin Analytics & Chelsea And Westminster Hospital FT: Using Artificial Intelligence As A Medical Device To Enable Dermatologists To Have More Time For Patients With Skin Cancer

In 2022, Skin Analytics implemented a skin cancer pathway using DERM, artificial intelligence as a medical device (AIaMD), at Chelsea and Westminster Foundation Trust. Since launching, the service has undergone extensive post-market surveillance and health economic modelling. The pathway has continued to enhance efficiency with skin cancer conversion rates increasing by 67 per cent and 94 per cent of patients avoiding an urgent face-to-face appointment. In essence, the implementation of AIaMD has helped to speed up patient access to skin cancer diagnosis and reserved CWFT’s dermatology capacity to treat patients with skin cancer.

Highly commended:

Changeology Group & Airedale General Hospital: Endoscopy Improvement Project - Improving Cancer Outcomes

Finalists

MSD and Edinburgh Cancer Centre: EPIC - Early Prehabilitation in Lung Cancer Project

Sanofi And The Christie FT: A Joint Working Agreement To Understand And Improve The Patient Journey And Experience Within The cSCC Service Across Greater Manchester

Topics

Winners of HSJ Partnership and inaugural Independent Healthcare Providers Awards revealed